For example, radiolabelling of human epidermal growth factor receptor 2 (HER2)antibody, trastuzumab with Zirconium-89 (89Zr) has been used to visualize and quantify HER2-expression in patients with HER2-positive breast cancer [9]. This evidence concerns the gene ERBB2 and breast cancer.